14 Best Affordable Stocks to Buy Under $20
On October 22, Alan Rechtschaffen, UBS Global Wealth senior portfolio manager, appeared on CNBC’s ‘Money Movers’ to talk about the latest trends in the market.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bourgeon Capital John Zaro | 720,000 | $14,544,000 | -1% | 2.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.86 | 1,113 | $20,988.06 | 13,027 | 2025-09-05 | Filing | |
| $9.60 | 104,500 | $1,003,409.00 | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | $997,013.10 | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | $43,840.00 | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | $4,829,700.00 | 1,500,000 | 2018-05-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.16 | 6,053 | $91,748.35 | 6,774 | 2025-08-01 | Filing | |
| $15.16 | 52,742 | $799,436.87 | 0 | 2025-08-01 | Filing | |
| $17.08 | 55,775 | $952,464.10 | 403,288 | 2025-06-12 | Filing | |
| $17.02 | 6,206 | $105,627.98 | 9,989 | 2025-06-03 | Filing | |
| $18.04 | 337,915 | $6,097,304.47 | 150,996 | 2025-05-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,328,356 | $168,232,791 | 0.23% | |
| 2. | 1,938,730 | $38,890,924 | 0.06% | |
| 3. | 724,950 | $14,643,990 | 0.04% | |
| 4. | 421,312 | $8,510,502 | 0.02% | |
| 5. | 370,436 | $7,482,807 | 0.86% |
News See All
Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory
We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.
13 Best Growth Stocks Under $25 to Buy Right Now
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
11 Dirt Cheap Stocks to Buy According to Analysts
Stocks gained more in afternoon trading after US Treasury Secretary Scott Bessent announced he would speak with his Chinese trade counterpart.
Teva Pharmaceutical Receives FDA Approval to Expand UZEDY Indication for Maintenance Treatment of Bipolar I Disorder
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best high volume stocks to buy according to Wall Street analysts.
14 Best High Volume Stocks to Buy According to Wall Street Analysts
On October 9, Keith Buchanan, Senior Portfolio Manager at GLOBALT Investments, appeared on CNBC and stated that the markets show mixed signals of risk and optimism.
BofA Raises Teva Pharmaceutical (TEVA) PT to $24, Amid "Pivot to Growth" Strategy Execution
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks under $100.
14 Most Promising Stocks Under $100
On October 10, Tom Lee of Fundstrat joined 'Closing Bell' on CNBC to suggest that the S&P can still get to at least 7,000 this year. Tom Lee stated that markets are attempting to balance a few things.
UBS Maintains its Buy Rating on Teva Pharmaceutical Industries Limited (TEVA); Raises Its Price Target to $26.00
UBS raised its 2030 sales estimate from $6.3 billion to $6.6 billion, taking into account possible income from Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s new inhaler DARI, which is anticipated...
Truist Securities Reaffirms Its Buy Rating for Teva Pharmaceutical Industries Limited (TEVA)
On September 23, 2025, Truist Securities reaffirmed its Buy rating for Teva Pharmaceutical Industries Limited (NYSE:TEVA), maintaining its $25 price target, following a recap call on Olanzapine LAI (long...
Hedge Fund Resource Center Billionaire Hedge Funds
